Abstract
The objective of the study is to investigate the effects of the Numb/Notch signal pathway on the radiosensitivity of lung cancer cell line H358. MTT assay and colony forming assay were used to detect the effects of different doses of X-rays and MW167 on the in vitro proliferation of the lung cancer cell line H358. Flow cytometry was applied to evaluate the effects of X rays on the apoptosis of H358. Scratch assay and Transwell invasion assay were used to examine the effects of X-rays on the migration and invasion abilities of H358. The mRNA and protein expressions in the signal pathway were detected by real-time PCR and western blot. Assays in vitro confirmed the effects of the Numb/Notch pathway inhibitor on the radiosensitivity to lung cancer. MW167 enhanced the inhibiting effects of X-ray on the proliferation of H358 cell line. After the addition of MW167, the apoptosis rates significantly increased, but the invasion and migration abilities decreased significantly. Meanwhile, MW167 could dose-dependently promote the increase of expression of Numb, which is the upstream gene of the Numb/Notch signaling pathway, but inhibit the expression of and HES1. In vivo experiments revealed that cell proliferation was suppressed in the radiation, pathway inhibitor, and pathway inhibitor + radiation groups, and the pathway inhibitor + radiation group exhibited more active anti-tumor ability when compared with the blank group (all P < 0.05); Numb expression was up-regulated, but Notch1 and HES1 expressions were down-regulated in those three groups, and also, the pathway inhibitor + radiation group exhibited more significant alternation when compared with the blank group (all P < 0.05); cell apoptosis was promoted in those three groups, and the pathway inhibitor + radiation group showed more active apoptosis when compared with the blank group (all P < 0.05). Repression of the Numb/Notch pathway enhances the effects of radiotherapy on the radiosensitivity of the lung cancer cell line H358, and thus the Numb/Notch pathway may be a new target of radiotherapy for lung cancer.
Similar content being viewed by others
References
Wang GF, Lai MD, Chen PH. Correlation of multiple primary lung cancer with bronchial and alveolar epithelial dysplasia. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2005;34(5):427–31.
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.
Xie SS, Li M, Zhou CC, Song XL, Wang CH. Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis. PLoS One. 2014;9(7):e103431.
Hillman GG, Singh-Gupta V, Runyan L, Yunker CK, Rakowski JT, Sarkar FH, et al. Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury. Radiother Oncol. 2011;101(2):329–36.
Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004;73:39–85.
Brognard J, Clark AS, Ni Y, Dennis PA. Akt/protein kinase b is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res. 2001;61(10):3986–97.
Wang XC, LQ D, Tian LL, HL W, Jiang XY, Zhang H, et al. Expression and function of mirna in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer. 2011;72(1):92–9.
Zhou C, YL W, Chen G, Feng J, Liu XQ, Wang C, et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced egfr mutation-positive non-small-cell lung cancer (optimal, ctong-0802): a multicentre, open-label, randomised, phase 3 study. Lancet Oncol. 2011;12(8):735–42.
Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–94.
Wharton KA, Johansen KM, Xu T, Artavanis-Tsakonas S. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing egf-like repeats. Cell. 1985;43(3 Pt 2):567–81.
Kidd S, Kelley MR, Young MW. Sequence of the notch locus of Drosophila melanogaster: relationship of the encoded protein to mammalian clotting and growth factors. Mol Cell Biol. 1986;6(9):3094–108.
Lai EC. Notch signaling: control of cell communication and cell fate. Development. 2004;131(5):965–73.
Leong KG, Karsan A. Recent insights into the role of notch signaling in tumorigenesis. Blood. 2006;107(6):2223–33.
Zhang XP, Zheng G, Zou L, Liu HL, Hou LH, Zhou P, et al. Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol Cell Biochem. 2008;307(1–2):101–8.
Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS. Role of notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 2004;6(6):R605–15.
Dho SE, French MB, Woods SA, McGlade CJ. Characterization of four mammalian numb protein isoforms. Identification of cytoplasmic and membrane-associated variants of the phosphotyrosine binding domain. J Biol Chem. 1999;274(46):33097–104.
Pece S, Confalonieri S, RR P, Di Fiore PP. Numbing down cancer by more than just a notch. Biochim Biophys Acta. 2011;1815(1):26–43.
Gulino A, Di Marcotullio L, Screpanti I. The multiple functions of numb. Exp Cell Res. 2010;316(6):900–6.
Tosoni D, Zecchini S, Coazzoli M, Colaluca I, Mazzarol G, Rubio A, et al. The numb/p53 circuitry couples replicative self-renewal and tumor suppression in mammary epithelial cells. J Cell Biol. 2015;211(4):845–62.
Katoh M, Katoh M. Numb is a break of Wnt-notch signaling cycle. Int J Mol Med. 2006;18(3):517–21.
Westhoff B, Colaluca IN, D’Ario G, Donzelli M, Tosoni D, Volorio S, et al. Alterations of the notch pathway in lung cancer. Proc Natl Acad Sci U S A. 2009;106(52):22293–8.
Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rational targeting of notch signaling in cancer. Oncogene. 2008;27(38):5124–31.
Cook J. Radiation sensitization of mammalian cells by metal chelators. Radiat Res. 2001;155(2):304–10.
Jia S, Zhang S, Yuan H, Chen N. Lunasin inhibits cell proliferation via apoptosis and reduces the production of proinflammatory cytokines in cultured rheumatoid arthritis synovial fibroblasts. Biomed Res Int. 2015;2015:346839.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in globocan 2012. Int J Cancer. 2015;136(5):E359–86.
Meder L, Konig K, Ozretic L, Schultheis AM, Ueckeroth F, Ade CP, et al. Notch, ascl1, p53 and rb alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas. Int J Cancer. 2016;138(4):927–38.
Wood PA, Yang X, Hrushesky WJ. Clock genes and cancer. Integr Cancer Ther. 2009;8(4):303–8.
Wang G, Mao W, Zheng S, Ye J. Epidermal growth factor receptor-regulated mir-125a-5p—a metastatic inhibitor of lung cancer. FEBS J. 2009;276(19):5571–8.
Cron KR, Zhu K, Kushwaha DS, Hsieh G, Merzon D, Rameseder J, et al. Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer. PLoS One. 2013;8(9):e73710.
Jiang L, Chang J, Zhang Q, Sun L, Qiu X. MicroRNA hsa-mir-125a-3p activates p53 and induces apoptosis in lung cancer cells. Cancer Investig. 2013;31(8):538–44.
Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage iiia or iiib non-small-cell lung cancer (rtog 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16(2):187–99.
Yan B, Omar FM, Das K, Ng WH, Lim C, Shiuan K, et al. Characterization of numb expression in astrocytomas. Neuropathology. 2008;28(5):479–84.
Zhao YJ, Han HZ, Liang Y, Shi CZ, Zhu QC, Yang J. Alternative splicing of VEGFA, app and numb genes in colorectal cancer. World J Gastroenterol. 2015;21(21):6550–60.
Wang C, Feng W, Zhang C. The expression and function of numb in endometrial cancer and the interaction with hdm2 and p53. J Cancer. 2015;6(10):1030–40.
Zhang XM, Wang JX, Lei XG, Cheng H, Wang LL, Yao GY. Regulation and mechanism of notch signaling pathway in small cell lung cancer. Zhonghua Bing Li Xue Za Zhi. 2010;39(2):95–9.
McGill MA, Dho SE, Weinmaster G, McGlade CJ. Numb regulates post-endocytic trafficking and degradation of notch1. J Biol Chem. 2009;284(39):26427–38.
Zhou P, Alfaro J, Chang EH, Zhao X, Porcionatto M, Segal RA. Numb links extracellular cues to intracellular polarity machinery to promote chemotaxis. Dev Cell. 2011;20(5):610–22.
Nickoloff BJ, Qin JZ, Chaturvedi V, Denning MF, Bonish B, Miele L. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through nf-kappab and PPAR-gamma. Cell Death Differ. 2002;9(8):842–55.
Pitsouli C, Delidakis C. The interplay between DSL proteins and ubiquitin ligases in notch signaling. Development. 2005;132(18):4041–50.
Okajima T, Irvine KD. Regulation of notch signaling by o-linked fucose. Cell. 2002;111(6):893–904.
Gordon WR, Vardar-Ulu D, Histen G, Sanchez-Irizarry C, Aster JC, Blacklow SC. Structural basis for autoinhibition of notch. Nat Struct Mol Biol. 2007;14(4):295–300.
Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, et al. A novel proteolytic cleavage involved in notch signaling: the role of the disintegrin-metalloprotease tace. Mol Cell. 2000;5(2):207–16.
Miele L, Golde T, Osborne B. Notch signaling in cancer. Curr Mol Med. 2006;6(8):905–18.
Gupta-Rossi N, Six E, LeBail O, Logeat F, Chastagner P, Olry A, et al. Monoubiquitination and endocytosis direct gamma-secretase cleavage of activated notch receptor. J Cell Biol. 2004;166(1):73–83.
Nam Y, Sliz P, Pear WS, Aster JC, Blacklow SC. Cooperative assembly of higher-order notch complexes functions as a switch to induce transcription. Proc Natl Acad Sci U S A. 2007;104(7):2103–8.
Yao J, Duan L, Fan M, X W. Gamma-secretase inhibitors exerts antitumor activity via down-regulation of notch and nuclear factor kappa b in human tongue carcinoma cells. Oral Dis. 2007;13(6):555–63.
Zhou M, Fan Z, Han R. Influence of blocking notch signaling pathway by γ-secretase inhibitor on proliferation of lung adenocarcinoma a549 cells. J Shanghai Jiaotong Univ (Med Sci). 2012;8(021).
Mizugaki H, Sakakibara-Konishi J, Ikezawa Y, Kikuchi J, Kikuchi E, Oizumi S, et al. Gamma-secretase inhibitor enhances antitumour effect of radiation in notch-expressing lung cancer. Br J Cancer. 2012;106(12):1953–9.
Kang J, Kim E, Kim W, Seong KM, Youn H, Kim JW, et al. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (emt) by mir-34a-mediated suppression of notch-1 expression in non-small cell lung cancer cell lines. J Biol Chem. 2013;288(38):27343–57.
Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, et al. Notch promotes radioresistance of glioma stem cells. Stem Cells. 2010;28(1):17–28.
Acknowledgments
We would like to acknowledge the helpful comments on this paper received from our reviewers.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Rights and permissions
About this article
Cite this article
Song, SG., Yu, HY., Ma, YW. et al. Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358. Tumor Biol. 37, 13705–13719 (2016). https://doi.org/10.1007/s13277-016-5134-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-016-5134-7